Physicochemical and Biological Characterization of the TLR7 Agonist SZU-106
This evaluation of SZU-106 supports its further development as a therapeutic TLR7 agonist, with formulation strategies representing the next stage for drug development.
Authors
- Sonja M. Kessler (ORCID: https://orcid.org/0000-0002-8591-851X)
- Christian Wischke (ORCID: https://orcid.org/0000-0001-5531-9033)
- Johannes Kipp
- Martin Herbst
Institutions
- Martin Luther University Halle-Wittenberg (DE)
Publication Details
- Journal
- Pharmaceutical Research
- Published
- 2026-02-26
- DOI
- https://doi.org/10.1007/s11095-026-04031-5
- Primary Topic
- Immune Response and Inflammation
- Type
- article
- Field-Weighted Citation Impact
- 0.00